[Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]

Nouv Presse Med. 1974 Mar 2;3(9):521-4.
[Article in French]
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Agranulocytosis / chemically induced
  • Alopecia / chemically induced
  • Child
  • Child, Preschool
  • Female
  • Hodgkin Disease / drug therapy
  • Humans
  • Infant
  • Leukemia / drug therapy*
  • Leukemia, Lymphoid / drug therapy
  • Leukemia, Monocytic, Acute / drug therapy
  • Leukemia, Myeloid, Acute / drug therapy
  • Lymphatic Diseases / drug therapy*
  • Lymphoma / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Non-Hodgkin / drug therapy
  • Male
  • Middle Aged
  • Podophyllotoxin / adverse effects
  • Podophyllotoxin / therapeutic use*
  • Thrombocytopenia / chemically induced

Substances

  • Podophyllotoxin